CCL2 and brain ischemia: The neuroprotective effect of TGF-β1 has been shown to be associated with the inhibition of chemokines, including monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) during cerebral ischemia and reperfusion (47).